Resideo Technologies (REZI) Financials

$41.13 +0.79 (+1.95%)

Closing price 05/6/2026 03:59 PM Eastern

Extended Trading

$41.10 -0.03 (-0.07%)

As of 07:17 AM Eastern

Annual Income Statements for Resideo Technologies

This table shows Resideo Technologies' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	177	-394	405	36	37	242	283	210	91	-562
Consolidated Net Income / (Loss)	177	-394	405	36	37	242	283	210	116	-527
Net Income / (Loss) Continuing Operations	177	-394	405	36	37	242	283	210	116	-527
Total Pre-Tax Income	310	166	104	71	101	353	418	313	221	-457
Total Operating Income	495	445	493	258	311	559	611	547	520	607
Total Gross Profit	1,365	1,316	1,425	1,277	1,344	1,584	1,766	1,696	1,901	2,196
Total Revenue	4,455	4,519	4,827	4,988	5,071	5,846	6,370	6,242	6,761	7,472
Operating Revenue	4,455	4,519	4,827	4,988	5,071	5,846	6,370	6,242	6,761	7,472
Total Cost of Revenue	3,090	3,203	3,402	3,711	3,727	4,262	4,604	4,546	4,860	5,276
Operating Cost of Revenue	3,090	3,203	3,402	3,711	3,727	4,262	4,604	4,546	4,860	5,276
Total Operating Expenses	870	871	932	1,019	1,033	1,025	1,155	1,149	1,381	1,589
Selling, General & Admin Expense	870	871	932	932	889	909	974	960	1,138	1,266
Research & Development Expense	-	-	-	-	74	86	111	109	111	167
Amortization Expense	-	-	-	-	30	30	35	38	80	122
Other Operating Expenses / (Income)	-	-	-	87	-	-	-	-	-	18
Restructuring Charge	-	-	-	-	40	0.00	35	42	52	16
Total Other Income / (Expense), net	-185	-279	-389	-187	-210	-206	-193	-234	-299	-1,064
Interest Expense	0.00	0.00	20	69	63	47	54	65	81	135
Other Income / (Expense), net	-185	-279	-369	-118	-147	-159	-139	-169	-218	-929
Income Tax Expense	133	560	-301	35	64	111	135	103	105	70
Preferred Stock Dividends Declared	-	-	-	-	-	-	0.00	0.00	19	35
Net Income / (Loss) Attributable to Noncontrolling Interest	-	-	-	-	-	-	0.00	0.00	6.00	0.00
Basic Earnings per Share	$1.44	($3.22)	$3.31	$0.29	$0.30	$1.68	$1.94	$1.43	$0.62	($3.77)
Weighted Average Basic Shares Outstanding	122.50M	122.50M	122.50M	122.72M	125M	144M	146M	147M	146M	149M
Diluted Earnings per Share	$1.44	($3.22)	$3.30	$0.29	$0.29	$1.63	$1.90	$1.42	$0.61	($3.77)
Weighted Average Diluted Shares Outstanding	122.50M	122.50M	122.62M	123.24M	126M	148M	149M	148M	149M	149M
Weighted Average Basic & Diluted Shares Outstanding	-	122.40M	122.40M	122.94M	143.14M	145.02M	146.62M	145.32M	147.88M	151.25M

This table shows Resideo Technologies' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/1/2023	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025
Net Income / (Loss) Attributable to Common Shareholders	50	21	82	43	28	11	7.00	-3.00	-833	131	143
Consolidated Net Income / (Loss)	50	21	82	43	30	20	23	6.00	-825	156	136
Net Income / (Loss) Continuing Operations	50	21	82	43	30	20	23	6.00	-825	156	136
Total Pre-Tax Income	94	37	101	73	59	44	45	15	-738	110	156
Total Operating Income	153	109	147	128	122	126	144	136	177	154	140
Total Gross Profit	436	417	425	400	447	524	530	511	569	556	560
Total Revenue	1,602	1,554	1,537	1,486	1,589	1,828	1,858	1,770	1,943	1,864	1,895
Operating Revenue	1,602	1,554	1,537	1,486	1,589	1,828	1,858	1,770	1,943	1,864	1,895
Total Cost of Revenue	1,166	1,137	1,112	1,086	1,142	1,304	1,328	1,259	1,374	1,308	1,335
Operating Cost of Revenue	1,166	1,137	1,112	1,086	1,142	1,304	1,328	1,259	1,374	1,308	1,335
Total Operating Expenses	283	308	278	272	325	398	386	375	392	402	420
Selling, General & Admin Expense	242	233	241	231	280	317	310	306	319	324	317
Research & Development Expense	29	28	27	25	21	23	42	35	41	44	47
Amortization Expense	10	9.00	10	9.00	13	29	29	30	30	31	31
Restructuring Charge	-	-	-	7.00	11	29	-	4.00	2.00	3.00	7.00
Total Other Income / (Expense), net	-59	-72	-46	-55	-63	-82	-99	-121	-915	-44	16
Interest Expense	17	16	15	13	15	27	26	25	24	37	49
Other Income / (Expense), net	-42	-56	-31	-42	-48	-55	-73	-96	-891	-7.00	65
Income Tax Expense	44	16	19	30	29	24	22	9.00	87	-46	20
Preferred Stock Dividends Declared	-	0.00	-	0.00	2.00	8.00	-	9.00	8.00	9.00	9.00
Basic Earnings per Share	$0.34	$0.14	$0.56	$0.29	$0.19	$0.07	$0.07	($0.02)	($5.59)	$0.88	$0.96
Weighted Average Basic Shares Outstanding	147M	147M	147M	146M	146M	147M	146M	148M	149M	149M	149M
Diluted Earnings per Share	$0.34	$0.14	$0.56	$0.29	$0.19	$0.07	$0.06	($0.02)	($5.59)	$0.85	$0.99
Weighted Average Diluted Shares Outstanding	149M	148M	148M	148M	149M	149M	149M	148M	149M	154M	149M
Weighted Average Basic & Diluted Shares Outstanding	147.65M	146.09M	145.32M	146.02M	146.41M	146.97M	147.88M	148.50M	148.76M	149.71M	151.25M

This table details how cash moves in and out of Resideo Technologies' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Net Change in Cash & Equivalents	-35	9.00	209	-143	395	262	-450	308	56	-31
Net Cash From Operating Activities	151	37	462	23	244	315	152	440	444	-1,137
Net Cash From Continuing Operating Activities	151	37	462	23	244	315	152	440	444	-1,137
Net Income / (Loss) Continuing Operations	177	-394	405	36	37	242	283	210	116	-527
Consolidated Net Income / (Loss)	177	-394	405	36	37	242	283	210	116	-527
Depreciation Expense	57	67	66	80	86	88	94	98	144	195
Non-Cash Adjustments To Reconcile Net Income	34	41	66	8.00	90	83	91	82	158	-546
Changes in Operating Assets and Liabilities, net	-124	323	-75	-101	31	-98	-316	50	26	-259
Net Cash From Investing Activities	-191	-51	-74	-112	-103	-65	-764	-44	-1,409	-39
Net Cash From Continuing Investing Activities	-191	-51	-74	-112	-103	-65	-764	-44	-1,409	-39
Purchase of Property, Plant & Equipment	-60	-51	-81	-95	-70	-63	-85	-105	-80	-116
Acquisitions	-131	0.00	0.00	-17	-35	-11	-665	-16	-1,337	0.00
Divestitures	-	-	-	-	-	0.00	0.00	86	0.00	77
Other Investing Activities, net	-	0.00	7.00	0.00	2.00	9.00	-14	-9.00	8.00	0.00
Net Cash From Financing Activities	4.00	21	-167	-53	253	20	170	-64	1,031	1,128
Net Cash From Continuing Financing Activities	4.00	21	-167	-53	253	20	170	-64	1,031	1,128
Repayment of Debt	-2.00	2.00	-29	-26	-26	-1,230	-30	-6.00	-597	-9.00
Repurchase of Common Equity	-	-	-	-	-	0.00	0.00	-41	-1.00	0.00
Payment of Dividends	-	-	-	-	-	-	0.00	0.00	-12	-35
Issuance of Debt	2.00	0.00	1,212	-27	0.00	1,250	200	0.00	1,176	1,201
Issuance of Preferred Equity	-	-	-	-	-	-	0.00	0.00	482	0.00
Other Financing Activities, net	4.00	19	-1,350	0.00	-	-	-	-17	-17	-29
Other Net Changes in Cash	-	2.00	-12	-1.00	-	-8.00	-8.00	-	-	17

This table details how cash moves in and out of Resideo Technologies' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/1/2023	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025
Net Change in Cash & Equivalents	87	-13	267	-33	-190	118	161	-115	176	-408	316
Net Cash From Operating Activities	121	60	263	2.00	92	147	203	-65	200	-1,571	299
Net Cash From Continuing Operating Activities	121	60	263	2.00	92	147	203	-65	200	-1,571	299
Net Income / (Loss) Continuing Operations	50	21	82	43	30	20	23	6.00	-825	156	136
Consolidated Net Income / (Loss)	50	21	82	43	30	20	23	6.00	-825	156	136
Depreciation Expense	25	22	27	24	28	46	46	47	49	49	50
Non-Cash Adjustments To Reconcile Net Income	17	49	-8.00	32	22	50	22	79	867	-1,618	126
Changes in Operating Assets and Liabilities, net	29	-32	162	-97	12	31	112	-197	109	-158	-13
Net Cash From Investing Activities	-29	-35	46	-22	-1,342	-22	-23	-31	-20	-28	40
Net Cash From Continuing Investing Activities	-29	-35	46	-22	-1,342	-22	-23	-31	-20	-28	40
Purchase of Property, Plant & Equipment	-29	-25	-31	-21	-15	-22	-22	-31	-20	-28	-37
Net Cash From Financing Activities	-9.00	-29	-17	-8.00	1,060	-9.00	-12	-22	-11	1,192	-31
Net Cash From Continuing Financing Activities	-9.00	-29	-17	-8.00	1,060	-9.00	-12	-22	-11	1,192	-31
Repayment of Debt	-15	-1.00	-4.00	-3.00	-5.00	-590	-12	2.00	-4.00	-1.00	-6.00
Payment of Dividends	-	-	-	0.00	-	-	-	-9.00	-8.00	-9.00	-9.00
Issuance of Debt	6.00	-	-	2.00	-	582	12	-	-	1,209	-10
Other Financing Activities, net	-	-	-	-7.00	-	-	-	-15	-1.00	-7.00	-6.00
Other Net Changes in Cash	4.00	-	-	-5.00	-	-	-7.00	-	-	-1.00	8.00

This table presents Resideo Technologies' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Total Assets	4,473	4,972	5,128	5,610	5,853	6,387	6,645	8,199	8,433
Total Current Assets	1,392	1,809	1,785	2,225	2,541	2,502	2,743	3,172	3,358
Cash & Equivalents	56	265	122	517	775	326	636	692	661
Accounts Receivable	802	821	817	863	876	1,002	973	1,023	1,073
Inventories, net	465	628	671	672	740	975	941	1,237	1,354
Other Current Assets	69	95	175	173	150	199	193	220	270
Plant, Property, & Equipment, net	265	300	316	318	287	366	390	410	447
Total Noncurrent Assets	2,816	2,863	3,027	3,067	3,025	3,519	3,512	4,617	4,628
Goodwill	2,648	2,634	2,642	2,691	2,661	2,724	2,705	3,072	3,100
Intangible Assets	140	133	-	-	120	475	461	1,176	1,091
Other Noncurrent Operating Assets	23	96	385	376	244	320	346	369	437
Total Liabilities & Shareholders' Equity	4,473	4,972	5,128	5,610	5,853	6,387	6,645	8,199	8,433
Total Liabilities	1,870	3,439	3,526	3,617	3,601	3,858	3,896	4,890	5,516
Total Current Liabilities	1,147	1,489	1,494	1,538	1,494	1,546	1,525	1,790	1,755
Accounts Payable	738	964	920	936	883	894	905	1,073	1,131
Accrued Expenses	409	503	552	595	601	640	620	717	624
Total Noncurrent Liabilities	723	1,950	2,032	2,079	2,107	2,312	2,371	3,100	3,761
Long-Term Debt	0.00	1,179	1,158	1,155	1,220	1,404	1,396	1,983	3,167
Other Noncurrent Operating Liabilities	346	771	874	924	887	908	975	1,117	594
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,603	1,533	1,602	1,993	2,252	2,529	2,749	3,309	2,917
Total Preferred & Common Equity	2,603	1,533	1,602	1,993	2,252	2,529	2,749	3,309	2,917
Preferred Stock	-	-	-	-	-	-	0.00	482	482
Total Common Equity	2,603	1,533	1,602	1,993	2,252	2,529	2,749	2,827	2,435
Common Stock	0.00	1,720	1,761	2,070	2,121	2,176	2,226	2,315	2,391
Retained Earnings	0.00	2.00	38	75	317	600	810	907	345
Treasury Stock	-	0.00	-3.00	-6.00	-21	-35	-93	-111	-144
Accumulated Other Comprehensive Income / (Loss)	-100	-189	-194	-146	-165	-212	-194	-284	-157

This table presents Resideo Technologies' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025
Period end date	10/1/2022	4/1/2023	7/1/2023	9/30/2023	3/30/2024	6/29/2024	9/28/2024	3/29/2025	6/28/2025	9/27/2025
Total Assets	6,262	6,399	6,536	6,459	6,520	7,984	8,135	8,074	8,515	8,188
Total Current Assets	2,450	2,495	2,622	2,615	2,677	2,884	3,037	3,061	3,392	3,072
Cash & Equivalents	252	292	381	368	603	413	531	577	753	345
Accounts Receivable	1,043	985	1,043	988	933	1,071	1,103	1,045	1,135	1,147
Inventories, net	957	1,008	1,001	970	929	1,188	1,197	1,228	1,259	1,328
Other Current Assets	198	210	197	289	212	212	206	211	245	252
Plant, Property, & Equipment, net	351	379	388	380	369	424	423	411	426	433
Total Noncurrent Assets	3,461	3,525	3,526	3,464	3,474	4,676	4,675	4,602	4,697	4,683
Goodwill	2,678	2,736	2,737	2,687	2,689	3,079	3,119	3,084	3,126	3,122
Intangible Assets	460	471	467	456	456	1,218	1,197	1,157	1,137	1,113
Other Noncurrent Operating Assets	323	318	322	321	329	379	359	361	434	448
Total Liabilities & Shareholders' Equity	6,262	6,399	6,536	6,459	6,520	7,984	8,135	8,074	8,515	8,188
Total Liabilities	3,862	3,795	3,859	3,814	3,751	4,690	4,781	4,727	5,901	5,417
Total Current Liabilities	1,542	1,469	1,524	1,467	1,385	1,594	1,672	1,578	3,382	1,632
Accounts Payable	936	894	948	863	858	980	1,021	971	1,102	1,037
Accrued Expenses	594	563	564	592	515	602	645	607	655	595
Total Noncurrent Liabilities	2,320	2,326	2,335	2,347	2,366	3,096	3,109	3,149	2,519	3,785
Long-Term Debt	1,407	1,402	1,400	1,397	1,394	1,979	1,983	1,983	1,983	3,169
Other Noncurrent Operating Liabilities	913	924	935	950	972	1,117	1,126	1,166	536	616
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	2,400	2,604	2,677	2,645	2,769	3,294	3,354	3,347	2,614	2,771
Total Preferred & Common Equity	2,400	2,604	2,677	2,645	2,769	3,294	3,354	3,347	2,614	2,771
Preferred Stock	-	-	-	-	-	482	482	482	482	483
Total Common Equity	2,400	2,604	2,677	2,645	2,769	2,812	2,872	2,865	2,132	2,290
Common Stock	2,162	2,191	2,204	2,219	2,243	2,276	2,294	2,333	2,349	2,375
Retained Earnings	561	657	707	728	853	881	893	904	71	218
Treasury Stock	-31	-44	-50	-81	-101	-103	-108	-126	-127	-136
Accumulated Other Comprehensive Income / (Loss)	-292	-200	-184	-221	-226	-242	-207	-246	-161	-168
Other Equity Adjustments	-	-	-	-	-	-	-	-	-	0.50

This table displays calculated financial ratios and metrics derived from Resideo Technologies' official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	1.44%	6.82%	3.34%	1.66%	15.28%	8.96%	-2.01%	8.31%	10.52%
EBITDA Growth	0.00%	-37.70%	-18.45%	15.79%	13.64%	95.20%	15.98%	-15.90%	-6.30%	-128.48%
EBIT Growth	0.00%	-46.45%	-25.30%	12.90%	17.14%	143.90%	18.00%	-19.92%	-20.11%	-206.62%
NOPAT Growth	0.00%	-473.71%	281.77%	-93.19%	-12.91%	236.37%	7.94%	-11.28%	-25.63%	55.67%
Net Income Growth	0.00%	-322.60%	202.79%	-91.11%	2.78%	554.05%	16.94%	-25.80%	-44.76%	-554.31%
EPS Growth	0.00%	-323.61%	202.48%	-91.21%	0.00%	462.07%	16.56%	-25.26%	-57.04%	-718.03%
Operating Cash Flow Growth	0.00%	-75.50%	1,148.65%	-95.02%	960.87%	29.10%	-51.75%	189.47%	0.91%	-356.08%
Free Cash Flow Firm Growth	0.00%	0.00%	155.45%	-103.01%	325.86%	131.16%	-258.59%	195.72%	-271.50%	51.34%
Invested Capital Growth	0.00%	0.00%	-3.06%	7.74%	-0.83%	2.62%	33.69%	-3.04%	31.09%	17.89%
Revenue Q/Q Growth	0.00%	0.00%	0.00%	0.77%	4.04%	-0.80%	1.69%	-0.37%	4.98%	0.50%
EBITDA Q/Q Growth	0.00%	0.00%	0.00%	-33.33%	212.50%	0.00%	-3.90%	7.45%	-5.51%	52.08%
EBIT Q/Q Growth	0.00%	0.00%	0.00%	-45.74%	1,922.22%	0.25%	-5.41%	8.93%	-12.97%	29.39%
NOPAT Q/Q Growth	0.00%	0.00%	0.00%	-12.30%	-29.54%	-0.01%	-8.48%	24.44%	-17.39%	-0.65%
Net Income Q/Q Growth	0.00%	0.00%	0.00%	-40.98%	219.35%	3.42%	-9.00%	25.75%	-33.71%	17.66%
EPS Q/Q Growth	0.00%	0.00%	0.00%	-40.82%	211.54%	-1.81%	-8.65%	25.66%	-45.05%	19.79%
Operating Cash Flow Q/Q Growth	0.00%	0.00%	99.14%	35.29%	31.89%	-11.27%	21.60%	39.24%	-11.90%	7.79%
Free Cash Flow Firm Q/Q Growth	0.00%	0.00%	0.00%	0.00%	-27.96%	-9.26%	-21.24%	171.15%	-2.82%	-12.05%
Invested Capital Q/Q Growth	0.00%	0.00%	0.00%	-1.26%	-1.09%	0.11%	1.46%	-4.80%	-4.41%	-3.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	30.64%	29.12%	29.52%	25.60%	26.50%	27.10%	27.72%	27.17%	28.12%	29.39%
EBITDA Margin	8.40%	5.16%	3.94%	4.41%	4.93%	8.35%	8.89%	7.63%	6.60%	-1.70%
Operating Margin	11.11%	9.85%	10.21%	5.17%	6.13%	9.56%	9.59%	8.76%	7.69%	8.12%
EBIT Margin	6.96%	3.67%	2.57%	2.81%	3.23%	6.84%	7.41%	6.06%	4.47%	-4.31%
Profit (Net Income) Margin	3.97%	-8.72%	8.39%	0.72%	0.73%	4.14%	4.44%	3.36%	1.72%	-7.05%
Tax Burden Percent	57.10%	-237.35%	389.42%	50.70%	36.63%	68.56%	67.70%	67.09%	52.49%	115.32%
Interest Burden Percent	100.00%	100.00%	83.87%	50.71%	61.59%	88.25%	88.56%	82.80%	73.18%	141.93%
Effective Tax Rate	42.90%	337.35%	-289.42%	49.30%	63.37%	31.44%	32.30%	32.91%	47.51%	0.00%
Return on Invested Capital (ROIC)	0.00%	-82.94%	76.55%	5.10%	4.30%	14.34%	13.08%	10.30%	6.73%	8.48%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	-2,447.95%	-267.74%	-4.41%	-4.73%	-11.34%	-3.84%	-6.68%	-8.57%	-41.66%
Return on Net Nonoperating Assets (RNNOA)	0.00%	52.66%	-56.97%	-2.80%	-2.24%	-2.94%	-1.24%	-2.34%	-2.90%	-25.41%
Return on Equity (ROE)	0.00%	-30.27%	19.58%	2.30%	2.06%	11.40%	11.84%	7.96%	3.83%	-16.93%
Cash Return on Invested Capital (CROIC)	0.00%	-282.94%	79.66%	-2.35%	5.13%	11.76%	-15.76%	13.38%	-20.18%	-7.94%
Operating Return on Assets (OROA)	0.00%	3.71%	2.63%	2.77%	3.05%	6.98%	7.71%	5.80%	4.07%	-3.87%
Return on Assets (ROA)	0.00%	-8.81%	8.58%	0.71%	0.69%	4.22%	4.62%	3.22%	1.56%	-6.34%
Return on Common Equity (ROCE)	0.00%	-30.27%	19.58%	2.30%	2.06%	11.40%	11.84%	7.96%	3.52%	-14.31%
Return on Equity Simple (ROE_SIMPLE)	0.00%	-15.14%	26.42%	2.25%	1.86%	10.75%	11.19%	7.64%	3.51%	0.00%
Net Operating Profit after Tax (NOPAT)	283	-1,056	1,920	131	114	383	414	367	273	425
NOPAT Margin	6.34%	-23.37%	39.77%	2.62%	2.25%	6.56%	6.49%	5.88%	4.04%	5.69%
Net Nonoperating Expense Percent (NNEP)	0.00%	2,365.02%	344.29%	9.51%	9.03%	25.68%	16.91%	16.97%	15.30%	50.14%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	10.49%	8.85%	5.16%	6.98%
Cost of Revenue to Revenue	69.36%	70.88%	70.48%	74.40%	73.50%	72.90%	72.28%	72.83%	71.88%	70.61%
SG&A Expenses to Revenue	19.53%	19.27%	19.31%	18.68%	17.53%	15.55%	15.29%	15.38%	16.83%	16.94%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	1.46%	1.47%	1.74%	1.75%	1.64%	2.24%
Operating Expenses to Revenue	19.53%	19.27%	19.31%	20.43%	20.37%	17.53%	18.13%	18.41%	20.43%	21.27%
Earnings before Interest and Taxes (EBIT)	310	166	124	140	164	400	472	378	302	-322
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	374	233	190	220	250	488	566	476	446	-127
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.00	0.00	1.65	0.91	1.32	1.67	0.95	1.00	1.20	2.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.00	0.00	0.52	0.29	0.52	0.64	0.38	0.44	0.50	0.70
Price to Earnings (P/E)	0.00	0.00	6.24	40.70	70.96	15.53	8.48	13.09	37.23	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	16.03%	2.46%	1.41%	6.44%	11.80%	7.64%	2.69%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	1.40	0.95	1.24	1.56	0.96	1.00	1.12	1.52
Enterprise Value to Revenue (EV/Rev)	0.00	0.00	0.72	0.51	0.64	0.72	0.55	0.56	0.76	1.10
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	18.23	11.47	13.08	8.63	6.16	7.37	11.57	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	27.93	18.02	19.94	10.53	7.39	9.28	17.09	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	1.80	19.29	28.71	10.99	8.43	9.56	18.91	19.41
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	7.50	109.71	13.40	13.38	22.95	7.98	11.62	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	1.73	0.00	24.06	13.41	0.00	7.36	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.78	0.74	0.58	0.55	0.56	0.51	0.60	1.09
Long-Term Debt to Equity	0.00	0.00	0.77	0.72	0.58	0.54	0.56	0.51	0.60	1.09
Financial Leverage	0.00	-0.02	0.21	0.64	0.47	0.26	0.32	0.35	0.34	0.61
Leverage Ratio	0.00	1.72	2.28	3.22	2.99	2.70	2.56	2.47	2.45	2.67
Compound Leverage Factor	0.00	1.72	1.92	1.63	1.84	2.38	2.27	2.04	1.79	3.79
Debt to Total Capital	0.00%	0.00%	43.93%	42.42%	36.83%	35.32%	35.89%	33.68%	37.47%	52.05%
Short-Term Debt to Total Capital	0.00%	0.00%	0.80%	0.79%	0.22%	0.29%	0.30%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	43.12%	41.62%	36.61%	35.04%	35.59%	33.68%	37.47%	52.05%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	9.11%	7.92%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	0.00%	100.00%	56.07%	57.58%	63.17%	64.68%	64.11%	66.32%	53.42%	40.02%
Debt to EBITDA	0.00	0.00	6.32	5.36	4.65	2.52	2.50	2.93	4.45	-24.94
Net Debt to EBITDA	0.00	0.00	4.93	4.81	2.58	0.93	1.93	1.60	2.89	-19.73
Long-Term Debt to EBITDA	0.00	0.00	6.21	5.26	4.62	2.50	2.48	2.93	4.45	-24.94
Debt to NOPAT	0.00	0.00	0.63	9.02	10.20	3.21	3.42	3.80	7.27	7.45
Net Debt to NOPAT	0.00	0.00	0.49	8.09	5.66	1.19	2.64	2.07	4.73	5.90
Long-Term Debt to NOPAT	0.00	0.00	0.61	8.85	10.14	3.18	3.39	3.80	7.27	7.45
Altman Z-Score	0.00	0.00	1.57	1.39	1.60	2.14	1.93	1.94	1.72	1.62
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.96%	15.48%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.00	1.21	1.21	1.19	1.45	1.70	1.62	1.80	1.77	1.91
Quick Ratio	0.00	0.75	0.73	0.63	0.90	1.11	0.86	1.06	0.96	0.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	0.00	-3,603	1,998	-60	136	314	-498	477	-818	-398
Operating Cash Flow to CapEx	251.67%	72.55%	570.37%	24.21%	348.57%	500.00%	178.82%	419.05%	555.00%	-980.17%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	99.89	-0.87	2.16	6.69	-9.23	7.34	-10.10	-2.95
Operating Cash Flow to Interest Expense	0.00	0.00	23.10	0.33	3.87	6.70	2.81	6.77	5.48	-8.42
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	19.05	-1.04	2.76	5.36	1.24	5.15	4.49	-9.28
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.01	1.02	0.99	0.94	1.02	1.04	0.96	0.91	0.90
Accounts Receivable Turnover	0.00	5.63	5.95	6.09	6.04	6.72	6.78	6.32	6.77	7.13
Inventory Turnover	0.00	6.89	6.23	5.71	5.55	6.04	5.37	4.75	4.46	4.07
Fixed Asset Turnover	0.00	17.05	17.09	16.19	16.00	19.33	19.51	16.51	16.90	17.44
Accounts Payable Turnover	0.00	4.34	4.00	3.94	4.02	4.69	5.18	5.05	4.91	4.79
Days Sales Outstanding (DSO)	0.00	64.78	61.36	59.93	60.46	54.29	53.80	57.74	53.88	51.19
Days Inventory Outstanding (DIO)	0.00	52.99	58.63	63.88	65.76	60.46	67.98	76.92	81.79	89.62
Days Payable Outstanding (DPO)	0.00	84.10	91.30	92.65	90.88	77.89	70.44	72.22	74.28	76.24
Cash Conversion Cycle (CCC)	0.00	33.67	28.69	31.16	35.34	36.86	51.35	62.44	61.39	64.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	0.00	2,547	2,469	2,660	2,638	2,707	3,619	3,509	4,600	5,423
Invested Capital Turnover	0.00	3.55	1.92	1.95	1.91	2.19	2.01	1.75	1.67	1.49
Increase / (Decrease) in Invested Capital	0.00	2,547	-78	191	-22	69	912	-110	1,091	823
Enterprise Value (EV)	0.00	0.00	3,463	2,523	3,271	4,213	3,489	3,509	5,161	8,246
Market Capitalization	0.00	0.00	2,527	1,465	2,626	3,758	2,399	2,749	3,388	5,258
Book Value per Share	$0.00	$21.25	$12.47	$13.04	$16.14	$15.60	$17.34	$18.82	$19.24	$16.26
Tangible Book Value per Share	$0.00	($1.51)	($10.04)	($8.47)	($5.65)	($3.66)	($4.59)	($2.85)	($9.67)	($11.73)
Total Capital	0.00	2,603	2,734	2,782	3,155	3,482	3,945	4,145	5,292	6,084
Total Debt	0.00	0.00	1,201	1,180	1,162	1,230	1,416	1,396	1,983	3,167
Total Long-Term Debt	0.00	0.00	1,179	1,158	1,155	1,220	1,404	1,396	1,983	3,167
Net Debt	0.00	-56	936	1,058	645	455	1,090	760	1,291	2,506
Capital Expenditures (CapEx)	60	51	81	95	70	63	85	105	80	116
Debt-free, Cash-free Net Working Capital (DFCFNWC)	0.00	189	77	191	177	282	642	582	690	942
Debt-free Net Working Capital (DFNWC)	0.00	245	342	313	694	1,057	968	1,218	1,382	1,603
Net Working Capital (NWC)	0.00	245	320	291	687	1,047	956	1,218	1,382	1,603
Net Nonoperating Expense (NNE)	106	-662	1,515	95	77	141	131	157	157	952
Net Nonoperating Obligations (NNO)	0.00	-56	936	1,058	645	455	1,090	760	1,291	2,506
Total Depreciation and Amortization (D&A)	64	67	66	80	86	88	94	98	144	195
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	4.18%	1.60%	3.83%	3.49%	4.82%	10.08%	9.32%	10.21%	12.61%
Debt-free Net Working Capital to Revenue	0.00%	5.42%	7.09%	6.28%	13.69%	18.08%	15.20%	19.51%	20.44%	21.45%
Net Working Capital to Revenue	0.00%	5.42%	6.63%	5.83%	13.55%	17.91%	15.01%	19.51%	20.44%	21.45%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.00	$0.00	$3.31	$0.29	$0.30	$1.68	$1.94	$1.43	$0.62	($3.77)
Adjusted Weighted Average Basic Shares Outstanding	0.00	0.00	122.50M	122.72M	125.35M	144.04M	146M	147M	146M	149M
Adjusted Diluted Earnings per Share	$0.00	$0.00	$3.30	$0.29	$0.29	$1.63	$1.90	$1.42	$0.61	($3.77)
Adjusted Weighted Average Diluted Shares Outstanding	0.00	0.00	122.62M	123.24M	126.32M	148.45M	149M	148M	149M	149M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	0.00	0.00	122.69M	122.94M	143.14M	145.02M	146.62M	145.32M	147.88M	151.25M
Normalized Net Operating Profit after Tax (NOPAT)	283	312	345	131	246	383	437	395	300	436
Normalized NOPAT Margin	6.34%	6.89%	7.15%	2.62%	4.85%	6.56%	6.87%	6.33%	4.44%	5.84%
Pre Tax Income Margin	6.96%	3.67%	2.15%	1.42%	1.99%	6.04%	6.56%	5.01%	3.27%	-6.12%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	6.20	2.03	2.60	8.51	8.74	5.82	3.73	-2.39
NOPAT to Interest Expense	0.00	0.00	95.99	1.90	1.81	8.15	7.66	5.65	3.37	3.15
EBIT Less CapEx to Interest Expense	0.00	0.00	2.15	0.65	1.49	7.17	7.17	4.20	2.74	-3.24
NOPAT Less CapEx to Interest Expense	0.00	0.00	91.94	0.52	0.70	6.81	6.09	4.03	2.38	2.29
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.34%	-6.64%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	19.52%	11.21%	-6.64%

This table displays calculated financial ratios and metrics derived from Resideo Technologies' official financial filings.

Metric	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025
Period end date	7/1/2023	9/30/2023	12/31/2023	3/30/2024	6/29/2024	9/28/2024	12/31/2024	3/29/2025	6/28/2025	9/27/2025	12/31/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.98%	-3.96%	-1.47%	-4.07%	-0.81%	17.63%	20.88%	19.11%	22.28%	1.97%	1.99%
EBITDA Growth	-19.53%	-44.44%	30.00%	-9.84%	-25.00%	56.00%	-18.18%	-20.91%	-751.96%	67.52%	117.95%
EBIT Growth	-22.92%	-52.25%	36.47%	-12.24%	-33.33%	33.96%	-38.79%	-53.49%	-1,064.86%	107.04%	188.73%
NOPAT Growth	-39.02%	-39.18%	118.58%	-22.36%	-23.78%	-7.42%	-38.33%	-27.85%	99.73%	281.33%	65.83%
Net Income Growth	-46.81%	-66.67%	110.26%	-24.56%	-40.00%	-4.76%	-71.95%	-86.05%	-2,850.00%	680.00%	491.30%
EPS Growth	-46.03%	-66.67%	107.41%	-23.68%	-44.12%	-50.00%	-89.29%	-106.90%	-3,042.11%	1,114.29%	1,550.00%
Operating Cash Flow Growth	245.71%	62.16%	89.21%	150.00%	-23.97%	145.00%	-22.81%	-3,350.00%	117.39%	-1,168.71%	47.29%
Free Cash Flow Firm Growth	91.36%	92.49%	126.75%	361.01%	-1,688.41%	-1,770.53%	-543.61%	-591.11%	204.53%	47.17%	31.10%
Invested Capital Growth	4.01%	3.34%	-3.04%	-4.13%	31.39%	30.55%	31.09%	33.06%	-21.10%	16.27%	17.89%
Revenue Q/Q Growth	3.42%	-3.00%	-1.09%	-3.32%	6.93%	15.04%	1.64%	-4.74%	9.77%	-4.07%	1.66%
EBITDA Q/Q Growth	11.48%	-44.85%	90.67%	-23.08%	-7.27%	14.71%	0.00%	-25.64%	-864.37%	129.47%	30.10%
EBIT Q/Q Growth	13.27%	-52.25%	118.87%	-25.86%	-13.95%	-4.05%	0.00%	-43.66%	-1,885.00%	120.59%	39.46%
NOPAT Q/Q Growth	-16.20%	-23.98%	92.91%	-36.82%	-17.72%	-7.68%	28.51%	-26.09%	127.76%	76.27%	-44.12%
Net Income Q/Q Growth	-12.28%	-58.00%	290.48%	-47.56%	-30.23%	-33.33%	15.00%	-73.91%	-13,850.00%	118.91%	-12.82%
EPS Q/Q Growth	-10.53%	-58.82%	300.00%	-48.21%	-34.48%	-63.16%	-14.29%	-133.33%	-27,850.00%	115.21%	16.47%
Operating Cash Flow Q/Q Growth	3,125.00%	-50.41%	338.33%	-99.24%	4,500.00%	59.78%	38.10%	-132.02%	407.69%	-885.50%	119.03%
Free Cash Flow Firm Q/Q Growth	29.89%	7.27%	501.41%	5.54%	-580.37%	3.02%	4.80%	-10.73%	202.25%	-149.01%	-24.15%
Invested Capital Q/Q Growth	-0.48%	-0.59%	-4.80%	1.45%	36.39%	-1.23%	-4.41%	3.33%	-19.12%	45.55%	-3.07%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	27.22%	26.83%	27.65%	26.92%	28.13%	28.67%	28.53%	28.87%	29.28%	29.83%	29.55%
EBITDA Margin	8.49%	4.83%	9.30%	7.40%	6.42%	6.40%	6.30%	4.92%	-34.23%	10.52%	13.46%
Operating Margin	9.55%	7.01%	9.56%	8.61%	7.68%	6.89%	7.75%	7.68%	9.11%	8.26%	7.39%
EBIT Margin	6.93%	3.41%	7.55%	5.79%	4.66%	3.88%	3.82%	2.26%	-36.75%	7.89%	10.82%
Profit (Net Income) Margin	3.12%	1.35%	5.34%	2.89%	1.89%	1.09%	1.24%	0.34%	-42.46%	8.37%	7.18%
Tax Burden Percent	53.19%	56.76%	81.19%	58.90%	50.85%	45.45%	51.11%	40.00%	111.79%	141.82%	87.18%
Interest Burden Percent	84.68%	69.81%	87.07%	84.88%	79.73%	61.97%	63.38%	37.50%	103.36%	74.83%	76.10%
Effective Tax Rate	46.81%	43.24%	18.81%	41.10%	49.15%	54.55%	48.89%	60.00%	0.00%	-41.82%	12.82%
Return on Invested Capital (ROIC)	8.84%	6.88%	13.60%	8.59%	5.61%	4.75%	6.61%	5.20%	10.83%	16.74%	9.60%
ROIC Less NNEP Spread (ROIC-NNEP)	5.99%	3.18%	9.56%	5.23%	3.16%	1.77%	1.67%	0.82%	-56.76%	13.83%	10.34%
Return on Net Nonoperating Assets (RNNOA)	2.60%	1.39%	3.35%	1.87%	1.38%	0.74%	0.57%	0.30%	-26.98%	9.67%	6.30%
Return on Equity (ROE)	11.44%	8.27%	16.95%	10.46%	6.99%	5.48%	7.17%	5.50%	-16.15%	26.41%	15.91%
Cash Return on Invested Capital (CROIC)	5.24%	4.85%	13.38%	13.68%	-19.44%	-18.72%	-20.18%	-22.22%	32.95%	-6.83%	-7.94%
Operating Return on Assets (OROA)	6.82%	3.36%	7.23%	5.54%	3.96%	3.43%	3.48%	2.18%	-32.96%	7.18%	9.72%
Return on Assets (ROA)	3.07%	1.33%	5.11%	2.77%	1.60%	0.97%	1.13%	0.33%	-38.08%	7.62%	6.45%
Return on Common Equity (ROCE)	11.44%	8.27%	16.95%	10.46%	6.43%	5.04%	6.60%	5.06%	-13.52%	22.25%	13.44%
Return on Equity Simple (ROE_SIMPLE)	7.81%	6.31%	0.00%	7.08%	5.34%	5.22%	0.00%	2.36%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	81	62	119	75	62	57	74	54	124	218	122
NOPAT Margin	5.08%	3.98%	7.76%	5.07%	3.90%	3.13%	3.96%	3.07%	6.38%	11.72%	6.44%
Net Nonoperating Expense Percent (NNEP)	2.85%	3.70%	4.04%	3.37%	2.46%	2.98%	4.93%	4.38%	67.59%	2.91%	-0.73%
Return On Investment Capital (ROIC_SIMPLE)	-	-	2.88%	-	-	-	1.39%	1.02%	2.70%	3.68%	2.01%
Cost of Revenue to Revenue	72.78%	73.17%	72.35%	73.08%	71.87%	71.33%	71.47%	71.13%	70.72%	70.17%	70.45%
SG&A Expenses to Revenue	15.11%	14.99%	15.68%	15.55%	17.62%	17.34%	16.68%	17.29%	16.42%	17.38%	16.73%
R&D to Revenue	1.81%	1.80%	1.76%	1.68%	1.32%	1.26%	2.26%	1.98%	2.11%	2.36%	2.48%
Operating Expenses to Revenue	17.67%	19.82%	18.09%	18.30%	20.45%	21.77%	20.78%	21.19%	20.18%	21.57%	22.16%
Earnings before Interest and Taxes (EBIT)	111	53	116	86	74	71	71	40	-714	147	205
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	136	75	143	110	102	117	117	87	-665	196	255
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	0.97	0.88	1.00	1.18	1.02	1.02	1.20	0.92	1.56	2.69	2.16
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	0.41	0.37	0.44	0.53	0.46	0.46	0.50	0.37	0.45	0.83	0.70
Price to Earnings (P/E)	12.43	13.97	13.09	16.71	16.23	17.67	37.23	58.56	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	8.04%	7.16%	7.64%	5.98%	6.16%	5.66%	2.69%	1.71%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.98	0.92	1.00	1.14	1.01	1.01	1.12	0.95	1.31	1.69	1.52
Enterprise Value to Revenue (EV/Rev)	0.57	0.54	0.56	0.66	0.80	0.76	0.76	0.64	0.68	1.27	1.10
Enterprise Value to EBITDA (EV/EBITDA)	7.21	7.62	7.37	8.79	11.43	10.32	11.57	10.69	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	8.96	9.72	9.28	11.14	14.94	14.04	17.09	17.67	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	10.88	11.44	9.56	11.82	14.90	14.75	18.91	17.68	12.37	22.11	19.41
Enterprise Value to Operating Cash Flow (EV/OCF)	12.39	10.68	7.98	9.14	11.79	9.67	11.62	12.00	10.41	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	19.06	19.18	7.36	8.17	0.00	0.00	0.00	0.00	3.51	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.53	0.53	0.51	0.51	0.60	0.59	0.60	0.59	0.76	1.14	1.09
Long-Term Debt to Equity	0.52	0.53	0.51	0.50	0.60	0.59	0.60	0.59	0.76	1.14	1.09
Financial Leverage	0.43	0.44	0.35	0.36	0.44	0.42	0.34	0.36	0.48	0.70	0.61
Leverage Ratio	2.53	2.52	2.47	2.40	2.43	2.43	2.45	2.39	2.79	2.67	2.67
Compound Leverage Factor	2.15	1.76	2.15	2.04	1.94	1.51	1.55	0.89	2.89	1.99	2.03
Debt to Total Capital	34.53%	34.76%	33.68%	33.68%	37.67%	37.23%	37.47%	37.20%	43.14%	53.35%	52.05%
Short-Term Debt to Total Capital	0.29%	0.30%	0.00%	0.29%	0.23%	0.11%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	34.24%	34.46%	33.68%	33.39%	37.45%	37.11%	37.47%	37.20%	43.14%	53.35%	52.05%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	9.12%	9.02%	9.11%	9.04%	10.49%	8.12%	7.92%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	65.47%	65.24%	66.32%	66.32%	53.21%	53.75%	53.42%	53.75%	46.38%	38.54%	40.02%
Debt to EBITDA	2.81	3.18	2.93	3.03	4.63	4.21	4.45	4.69	-5.76	-11.96	-24.94
Net Debt to EBITDA	2.05	2.35	1.60	1.73	3.67	3.09	2.89	3.32	-3.58	-10.66	-19.73
Long-Term Debt to EBITDA	2.78	3.15	2.93	3.00	4.60	4.20	4.45	4.69	-5.76	-11.96	-24.94
Debt to NOPAT	4.23	4.78	3.80	4.07	6.04	6.02	7.27	7.75	4.86	7.41	7.45
Net Debt to NOPAT	3.09	3.53	2.07	2.33	4.78	4.41	4.73	5.49	3.01	6.60	5.90
Long-Term Debt to NOPAT	4.20	4.74	3.80	4.04	6.00	6.00	7.27	7.75	4.86	7.41	7.45
Altman Z-Score	1.78	1.74	1.81	1.94	1.52	1.54	1.63	1.60	0.94	1.90	1.82
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	8.07%	8.03%	7.96%	7.88%	16.32%	15.73%	15.48%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.72	1.78	1.80	1.93	1.81	1.82	1.77	1.94	1.00	1.88	1.91
Quick Ratio	0.93	0.92	1.06	1.11	0.93	0.98	0.96	1.03	0.56	0.91	0.99
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-62	-57	229	229	-1,102	-1,069	-1,017	-1,127	1,152	-565	-701
Operating Cash Flow to CapEx	417.24%	240.00%	848.39%	9.52%	613.33%	668.18%	922.73%	-209.68%	1,000.00%	-5,610.71%	808.11%
Free Cash Flow to Firm to Interest Expense	-3.62	-3.57	15.29	17.65	-73.46	-39.58	-39.13	-45.06	48.00	-15.26	-14.31
Operating Cash Flow to Interest Expense	7.12	3.75	17.53	0.15	6.13	5.44	7.81	-2.60	8.33	-42.46	6.10
Operating Cash Flow Less CapEx to Interest Expense	5.41	2.19	15.47	-1.46	5.13	4.63	6.96	-3.84	7.50	-43.22	5.35
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.98	0.99	0.96	0.96	0.85	0.88	0.91	0.97	0.90	0.91	0.90
Accounts Receivable Turnover	5.98	6.17	6.32	6.44	5.83	6.16	6.77	7.12	6.71	6.61	7.13
Inventory Turnover	4.68	4.74	4.75	4.65	4.09	4.29	4.46	4.67	4.30	4.17	4.07
Fixed Asset Turnover	16.85	17.14	16.51	16.52	15.19	16.04	16.90	18.06	17.41	17.37	17.44
Accounts Payable Turnover	4.77	5.07	5.05	5.14	4.64	4.93	4.91	5.50	5.06	5.12	4.79
Days Sales Outstanding (DSO)	61.02	59.16	57.74	56.65	62.57	59.26	53.88	51.24	54.41	55.23	51.19
Days Inventory Outstanding (DIO)	78.00	77.07	76.92	78.54	89.23	85.16	81.79	78.21	84.82	87.46	89.62
Days Payable Outstanding (DPO)	76.54	71.95	72.22	71.04	78.59	74.04	74.28	66.32	72.17	71.28	76.24
Cash Conversion Cycle (CCC)	62.48	64.28	62.44	64.15	73.21	70.38	61.39	63.13	67.06	71.40	64.58
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,708	3,686	3,509	3,572	4,872	4,812	4,600	4,753	3,844	5,595	5,423
Invested Capital Turnover	1.74	1.73	1.75	1.69	1.44	1.52	1.67	1.69	1.70	1.43	1.49
Increase / (Decrease) in Invested Capital	143	119	-110	-154	1,164	1,126	1,091	1,181	-1,028	783	823
Enterprise Value (EV)	3,629	3,374	3,509	4,078	4,916	4,873	5,161	4,523	5,047	9,455	8,246
Market Capitalization	2,598	2,333	2,749	3,275	2,856	2,933	3,388	2,635	3,335	6,148	5,258
Book Value per Share	$18.20	$17.91	$18.82	$18.97	$19.26	$19.62	$19.24	$19.37	$14.36	$15.39	$16.26
Tangible Book Value per Share	($3.58)	($3.37)	($2.85)	($2.58)	($10.17)	($9.86)	($9.67)	($9.31)	($14.35)	($13.08)	($11.73)
Total Capital	4,089	4,054	4,145	4,175	5,285	5,343	5,292	5,330	4,597	5,940	6,084
Total Debt	1,412	1,409	1,396	1,406	1,991	1,989	1,983	1,983	1,983	3,169	3,167
Total Long-Term Debt	1,400	1,397	1,396	1,394	1,979	1,983	1,983	1,983	1,983	3,169	3,167
Net Debt	1,031	1,041	760	803	1,578	1,458	1,291	1,406	1,230	2,824	2,506
Capital Expenditures (CapEx)	29	25	31	21	15	22	22	31	20	28	37
Debt-free, Cash-free Net Working Capital (DFCFNWC)	729	792	582	701	889	840	690	906	-743	1,095	942
Debt-free Net Working Capital (DFNWC)	1,110	1,160	1,218	1,304	1,302	1,371	1,382	1,483	10	1,440	1,603
Net Working Capital (NWC)	1,098	1,148	1,218	1,292	1,290	1,365	1,382	1,483	10	1,440	1,603
Net Nonoperating Expense (NNE)	31	41	37	32	32	37	51	48	949	62	-14
Net Nonoperating Obligations (NNO)	1,031	1,041	760	803	1,578	1,458	1,291	1,406	1,230	2,824	2,506
Total Depreciation and Amortization (D&A)	25	22	27	24	28	46	46	47	49	49	50
Debt-free, Cash-free Net Working Capital to Revenue	11.52%	12.64%	9.32%	11.34%	14.42%	13.04%	10.21%	12.86%	-10.04%	14.73%	12.61%
Debt-free Net Working Capital to Revenue	17.54%	18.52%	19.51%	21.10%	21.12%	21.29%	20.44%	21.05%	0.14%	19.37%	21.45%
Net Working Capital to Revenue	17.35%	18.32%	19.51%	20.91%	20.92%	21.20%	20.44%	21.05%	0.14%	19.37%	21.45%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.34	$0.14	$0.56	$0.29	$0.19	$0.07	$0.07	($0.02)	($5.59)	$0.88	$0.96
Adjusted Weighted Average Basic Shares Outstanding	147M	147M	147M	146M	146M	147M	146M	148M	149M	149M	149M
Adjusted Diluted Earnings per Share	$0.34	$0.14	$0.56	$0.29	$0.19	$0.07	$0.06	($0.02)	($5.59)	$0.85	$0.99
Adjusted Weighted Average Diluted Shares Outstanding	149M	148M	148M	148M	149M	149M	149M	148M	149M	154M	149M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	147.65M	146.09M	145.32M	146.02M	146.41M	146.97M	147.88M	148.50M	148.76M	149.71M	151.25M
Normalized Net Operating Profit after Tax (NOPAT)	82	83	119	80	68	109	74	98	125	110	128
Normalized NOPAT Margin	5.15%	5.37%	7.76%	5.35%	4.26%	5.94%	3.96%	5.54%	6.45%	5.90%	6.76%
Pre Tax Income Margin	5.87%	2.38%	6.57%	4.91%	3.71%	2.41%	2.42%	0.85%	-37.98%	5.90%	8.23%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	6.53	3.31	7.73	6.62	4.93	2.63	2.73	1.60	-29.75	3.97	4.18
NOPAT to Interest Expense	4.79	3.87	7.96	5.80	4.14	2.12	2.83	2.18	5.16	5.90	2.49
EBIT Less CapEx to Interest Expense	4.82	1.75	5.67	5.00	3.93	1.81	1.88	0.36	-30.58	3.22	3.43
NOPAT Less CapEx to Interest Expense	3.08	2.30	5.89	4.18	3.14	1.31	1.98	0.94	4.33	5.15	1.74
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.34%	26.58%	-3.74%	-5.47%	-6.64%
Augmented Payout Ratio	0.00%	16.77%	19.52%	21.43%	0.00%	8.00%	11.21%	26.58%	-3.74%	-5.47%	-6.64%

Financials Breakdown Chart

Key Financial Trends

Resideo Technologies (NYSE: REZI) has shown relatively stable top-line performance in the last four years, with quarterly revenue generally in the $1.5–$2.0 billion range. Gross margins have stayed in the high-20s to low-30s, and operating profitability has been supported by a mix of moderate SG&A, R&D, and amortization expense. 2025 brought some volatility, including a large negative quarterly swing in mid-year driven by non-operating items, but late-2025 results improved with a solid Q4 showing positive net income to common and a strong cash-flow infusion. The company remains financially leveraged, with meaningful debt on the balance sheet, and cash flows have fluctuated quarter to quarter. Investors should weigh the improving near-term profitability and cash generation against the higher leverage and episodic earnings volatility observed over the period.

Revenue stability and modest growth in late 2025: Q4 2025 revenue was $1.895B, up modestly from Q4 2024’s $1.858B, signaling continued demand in the core business.
Healthy gross margins maintained: Q4 2025 gross margin around 29.6% (560M gross profit on 1.895B revenue), consistent with recent quarters.
Bottom-line improvement in the latest quarter: Net income attributable to common shareholders reached $143M in Q4 2025, with diluted EPS about $0.99, versus much smaller or negative earnings in earlier periods.
Strong cash generation in Q4 2025: Net cash from continuing operating activities was $299M, with capex of $37M, implying roughly $262M of free cash flow for the quarter.
Solid equity base: Total common equity around $2.29B in 2025 (Q3), providing a reasonable equity buffer relative to debt load.

Debt load remains elevated: Long-term debt around $3.17B and total liabilities ≈$5.42B (Q3 2025), yielding a fairly high leverage profile that could pressure financial flexibility during downturns.
EPS and quarterly variability: Earnings per share and quarterly results have shown variability across quarters, with some quarters modestly positive and others less so, reflecting seasonality and non-operating effects.

Significant quarterly earnings volatility in 2025: Q2 2025 showed a large net loss to common (approximately -$833M to common shareholders, with a substantial negative pretax and a big negative swing from non-operating items), highlighting earnings volatility driven by one-off or non-operating factors.
Cash-flow volatility in mid-2025: Q3 2025 featured a negative net cash from continuing operating activities (about -$1.57B), indicating substantial working capital or non-operating headwinds during that quarter.
Debt-funded financing activity: The 2025 Q3 period included a large debt issuance (about $1.21B) to fund financing activities, underscoring ongoing reliance on leverage to support liquidity and growth needs.

05/07/26 05:59 AM ETAI Generated. May Contain Errors.

Frequently Asked Questions About Resideo Technologies' Financials

When does Resideo Technologies' financial year end?

According to the most recent income statement we have on file, Resideo Technologies' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

How has Resideo Technologies' net income changed over the last 9 years?

Resideo Technologies' net income appears to be on a downward trend, with a most recent value of -$527 million in 2025, falling from $177 million in 2016. The previous period was $116 million in 2024. Check out Resideo Technologies' forecast to explore projected trends and price targets.

What is Resideo Technologies' operating income?

Resideo Technologies' total operating income in 2025 was $607 million, based on the following breakdown:

Total Gross Profit: $2.20 billion
Total Operating Expenses: $1.59 billion

How has Resideo Technologies' revenue changed over the last 9 years?

Over the last 9 years, Resideo Technologies' total revenue changed from $4.46 billion in 2016 to $7.47 billion in 2025, a change of 67.7%.

How much debt does Resideo Technologies have?

Resideo Technologies' total liabilities were at $5.52 billion at the end of 2025, a 12.8% increase from 2024, and a 195.0% increase since 2017.

How much cash does Resideo Technologies have?

In the past 8 years, Resideo Technologies' cash and equivalents has ranged from $56 million in 2017 to $775 million in 2021, and is currently $661 million as of their latest financial filing in 2025.

How has Resideo Technologies' book value per share changed over the last 9 years?

Over the last 9 years, Resideo Technologies' book value per share changed from 0.00 in 2016 to 16.26 in 2025, a change of 1,626.4%.

Related Companies

Financial statements for NYSE:REZI last updated on 2/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Resideo Technologies (REZI) Financials

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Resideo Technologies' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Resideo Technologies (REZI) Financials

Annual Income Statements for Resideo Technologies

Quarterly Income Statements for Resideo Technologies

Annual Cash Flow Statements for Resideo Technologies

Quarterly Cash Flow Statements for Resideo Technologies

Annual Balance Sheets for Resideo Technologies

Quarterly Balance Sheets for Resideo Technologies

Annual Metrics And Ratios for Resideo Technologies

Quarterly Metrics And Ratios for Resideo Technologies

Financials Breakdown Chart

Key Financial Trends

Frequently Asked Questions About Resideo Technologies' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools